Clinical Study on Flumatinib Mesylate Combined with Chemotherapy Followed by Autologous Hematopoietic Cell Transplantation in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
Diseases and Research · 2023
DOI: 10.54457/dr.202301002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases and Research, 2023. Verfasst von Shaojuan Cui und 6 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cui, S., Tan, X., Deng, J., Yang, Q., Yao, J., Zhang, N., & Shen, Y. (2023). Clinical Study on Flumatinib Mesylate Combined with Chemotherapy Followed by Autologous Hematopoietic Cell Transplantation in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia. Diseases and Research. https://doi.org/10.54457/dr.202301002
Vancouver
Cui S, Tan X, Deng J, Yang Q, Yao J, Zhang N, et al. Clinical Study on Flumatinib Mesylate Combined with Chemotherapy Followed by Autologous Hematopoietic Cell Transplantation in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia. Diseases and Research. 2023. doi:10.54457/dr.202301002
BibTeX
@article{Cui2023,
author = {Cui, Shaojuan and Tan, Xiaoyan and Deng, Jianchuan and Yang, Qing and Yao, Jia and Zhang, Nan and Shen, Yan},
title = {Clinical Study on Flumatinib Mesylate Combined with Chemotherapy Followed by Autologous Hematopoietic Cell Transplantation in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia},
journal = {Diseases and Research},
year = {2023},
doi = {10.54457/dr.202301002}
}
EUVIMED